$CRSP CRISPR Therapeutics AG Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in CRISPR Therapeutics AG.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in CRISPR Therapeutics AG. Insider overview, share value development, latest insider transactions and email notifications about new events in CRISPR Therapeutics AG for free.
IRS Number: 473173478
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Trading Symbol: CRSP
Company Address: BAARERSTRASSE 14 ZUG CH-6300
Phone number: +41 (0)41 561 32
Former name: Inception Genomics AG
Market Capitalization: $605.88M
Prev close: $15.75
Average Daily Volume: 66,397
Days Low: $15.22
Year Low: $13.75
Year High: $25.00
CRISPR Therapeutics AG Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 17 2021 | CRSP | CRISPR Therapeutic ... | Kulkarni Samarth | Chief Executive Off ... | Option Exercise | M | 12.57 | 30,000 | 377,100 | 63,333 | |
| Jun 17 2021 | CRSP | CRISPR Therapeutic ... | Kulkarni Samarth | Chief Executive Off ... | Sell | S | 127.51 | 3,488 | 444,755 | 187,719 | 191.2 K to 187.7 K (-1.82 %) |
| Jun 17 2021 | CRSP | CRISPR Therapeutic ... | Kulkarni Samarth | Chief Executive Off ... | Sell | S | 126.86 | 16,129 | 2,046,125 | 191,207 | 207.3 K to 191.2 K (-7.78 %) |
| Jun 17 2021 | CRSP | CRISPR Therapeutic ... | Kulkarni Samarth | Chief Executive Off ... | Sell | S | 125.39 | 10,383 | 1,301,924 | 207,336 | 217.7 K to 207.3 K (-4.77 %) |
| Jun 17 2021 | CRSP | CRISPR Therapeutic ... | Kulkarni Samarth | Chief Executive Off ... | Buy | M | 12.57 | 30,000 | 377,100 | 217,719 | 187.7 K to 217.7 K (+15.98 %) |
| Mar 25 2021 | CRSP | CRISPR Therapeutic ... | Klein Lawrence Otto | CBO & COO | Option Exercise | M | 44.67 | 12,000 | 536,040 | 43,000 | |
| Mar 25 2021 | CRSP | CRISPR Therapeutic ... | Klein Lawrence Otto | CBO & COO | Option Exercise | M | 40.87 | 20,000 | 817,400 | 25,000 | |
| Mar 25 2021 | CRSP | CRISPR Therapeutic ... | Klein Lawrence Otto | CBO & COO | Option Exercise | M | 29.87 | 10,000 | 298,700 | 10,000 | |
| Mar 25 2021 | CRSP | CRISPR Therapeutic ... | Klein Lawrence Otto | CBO & COO | Option Exercise | M | 51.49 | 22,000 | 1,132,780 | 38,000 | |
| Mar 25 2021 | CRSP | CRISPR Therapeutic ... | Klein Lawrence Otto | CBO & COO | Option Exercise | M | 17.66 | 12,000 | 211,920 | 3,000 | |
| Mar 25 2021 | CRSP | CRISPR Therapeutic ... | Klein Lawrence Otto | CBO & COO | Option Exercise | M | 14.43 | 12,000 | 173,160 | 2,666 | |
| Mar 25 2021 | CRSP | CRISPR Therapeutic ... | Klein Lawrence Otto | CBO & COO | Sell | S | 126.97 | 12,000 | 1,523,640 | 1,050 | 13.1 K to 1.1 K (-91.95 %) |
| Mar 25 2021 | CRSP | CRISPR Therapeutic ... | Klein Lawrence Otto | CBO & COO | Sell | S | 128.20 | 88,000 | 11,281,600 | 13,050 | 101.1 K to 13.1 K (-87.09 %) |
| Mar 25 2021 | CRSP | CRISPR Therapeutic ... | Klein Lawrence Otto | CBO & COO | Buy | M | 17.66 | 12,000 | 211,920 | 101,050 | 89.1 K to 101.1 K (+13.48 %) |
| Mar 25 2021 | CRSP | CRISPR Therapeutic ... | Klein Lawrence Otto | CBO & COO | Buy | M | 14.43 | 12,000 | 173,160 | 89,050 | 77.1 K to 89.1 K (+15.57 %) |